According to the World Health Organization, as of November 30, 2020, 62,195,274 confirmed cases of COVID-19 were officially registered worldwide, 1,453,355 of which were fatal. The number of cases increases daily [1, 2]. In this regard, the interaction of COVID-19 with other pathogens of infectious diseases is particularly relevant, it determines significant changes in epidemiological patterns. The presence of such manifestations as acute respiratory distress syndrome and decreased immunological reactivity in the new coronavirus infection contributes to the epidemic spread of chronic infections, such as mycobacteriosis, including tuberculosis [3–6].
When the World Health Organization declared a pandemic caused by the new coronavirus infection in March 2020, the health system of the Kyrgyz Republic had a low level of readiness to protect its citizens. There was a shortage of beds and doctors, a lack of medicines, equipment and personal protective equipment (PPE) for healthcare providers.
From March to November 30, 2020, 72,807 cases of coronavirus infection were registered in the Kyrgyz Republic, 3,910 of them in healthcare providers. Besides, cases of COVID-19 began to be registered among patients with pulmonary tuberculosis. The fact that mechanisms and ways of transmission of new coronavirus infection and tuberculosis are similar, increases the risk of pathogens spread and determines common preventive approaches [7].
The work aimed to evaluate the effectiveness of anti-epidemic measures to prevent the spread of COVID-19 among patients and medical personnel in the anti-tuberculosis hospital during the pandemic.
The material for the study was the medical records of patients undergoing inpatient treatment in the R.G. Bauer Jalal-Abad Regional Centre for Tuberculosis Control in Jalal-Abad, as well as documents confirming the organization and implementation of anti-epidemic measures aimed at preventing the spread of COVID-19 among patients and medical personnel.